🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07622654
Recruiting Not applicable

Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity

NCT07622654 · tracked via the Priya Life Science Turkey tracker
Sponsor
Mehmet Emrah Karadere
Phase
Not applicable
Started
2025-10-01
Last updated
2026-06-03

Condition(s) studied

OCDObsessive - Compulsive Disorder

Investigational drug(s) / intervention(s)

Emotion-Focused Acceptance and Commitment Therapy (ACT) Group Psychotherapy

Emotion-Focused Acceptance and Commitment Therapy (ACT) Group Psychotherapy: Structured group psychotherapy based on ACT principles targeting emotional awareness, acceptance of emotional experiences, cognitive defusion, present-moment focus, values clarification and committed action. Sessions are conducted face-to-face, once weekly, 2 hours per session, for 10-12 weeks.

Study summary

This study aims to investigate the effect of Emotion-Focused Acceptance and Commitment Therapy (ACT) group psychotherapy on obsessive-compulsive disorder (OCD) symptom severity. Participants with OCD will be randomly assigned to either an ACT-based group psychotherapy arm or a supportive group psychotherapy arm. Each arm consists of 10 to 12 weekly sessions of 2 hours. Symptom severity, psychological flexibility, emotional awareness, functioning and quality of life will be assessed before and after the intervention.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of Obsessive-Compulsive Disorder according to DSM-5 criteria * Age between 18-65 years * Minimum literacy level * Willingness to participate and providing informed consent Exclusion Criteria: * Age over 65 years * Diagnosis of alcohol or substance use disorder * Comorbid psychotic disorder or intellectual disability * Any change in psychiatric treatment (medication or psychotherapy) in the last 3 months * Comorbid psychiatric disorder that would impair group therapy compliance * History of cognitive impairment due to dementia, organic brain syndrome or other neurological/organic pathology

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Goztepe Prof. Dr. Suleyman Yalcin City Hospital Istanbul Istanbul Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07622654 on ClinicalTrials.gov ↗ ← All trials in Turkey